Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M26,491Revenue $M580Net Margin (%)-127.3Z-Score10.8
Enterprise Value $M25,932EPS $-3.1Operating Margin %-119.4F-Score3
P/E(ttm))0Cash Flow Per Share $-0.3Pre-tax Margin (%)-126.7Higher ROA y-yN
Price/Book26.710-y EBITDA Growth Rate %0Quick Ratio4.1Cash flow > EarningsY
Price/Sales48.45-y EBITDA Growth Rate %0Current Ratio4.2Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-32.5Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-61.6Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M241ROI % (ttm)-31.5Gross Margin Increase y-yY

Gurus Latest Trades with VRTX

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VRTXAndreas Halvorsen 2014-12-31 Buy 0.42%$101.1 - $120.78
($112.7)
$ 119.436%New holding, 764200 sh.764,200
VRTXVanguard Health Care Fund 2014-12-31 Reduce-0.58%$101.1 - $120.78
($112.61)
$ 119.436%Reduce -16.93%9,808,860
VRTXKen Fisher 2014-09-30 Reduce$84.74 - $113.9
($94.97)
$ 119.4326%Reduce -31.99%4,593
VRTXKen Fisher 2014-06-30 Buy $62.44 - $93.77
($69.73)
$ 119.4371%New holding, 6753 sh.6,753
VRTXJohn Burbank 2014-06-30 Sold Out -0.01%$62.44 - $93.77
($69.73)
$ 119.4371%Sold Out0
VRTXGeorge Soros 2014-06-30 Sold Out -0.01%$62.44 - $93.77
($69.73)
$ 119.4371%Sold Out0
VRTXVanguard Health Care Fund 2014-03-31 Add0.13%$67.8 - $85.48
($79.08)
$ 119.4351%Add 5.89%11,628,500
VRTXGeorge Soros 2014-03-31 Buy 0.01%$67.8 - $85.48
($79.17)
$ 119.4351%New holding, 10000 sh.10,000
VRTXJohn Burbank 2014-03-31 Buy 0.01%$67.8 - $85.48
($79.17)
$ 119.4351%New holding, 2872 sh.2,872
VRTXVanguard Health Care Fund 2013-12-31 Add0.88%$60.18 - $77.83
($69.45)
$ 119.4372%Add 54.06%10,981,500
VRTXVanguard Health Care Fund 2013-09-30 Add0.29%$74.53 - $88.51
($79.62)
$ 119.4350%Add 19%7,127,997
VRTXVanguard Health Care Fund 2013-06-30 Add1.05%$52.6 - $85.6
($73.64)
$ 119.4362%Add 140.58%5,990,000
VRTXAndreas Halvorsen 2013-06-30 Sold Out -0.26%$52.6 - $85.6
($73.64)
$ 119.4362%Sold Out0
VRTXNWQ Managers 2013-06-30 Sold Out -0.09%$52.6 - $85.6
($73.64)
$ 119.4362%Sold Out0
VRTXAndreas Halvorsen 2013-03-31 Buy 0.26%$41.9 - $54.97
($47.91)
$ 119.43149%New holding, 780500 sh.780,500
VRTXNWQ Managers 2013-03-31 Reduce-0.02%$41.9 - $54.97
($47.91)
$ 119.43149%Reduce -23.44%191,032
VRTXDaniel Loeb 2012-12-31 Sold Out -0.77%$38.88 - $59.42
($46.08)
$ 119.43159%Sold Out0
VRTXJohn Burbank 2012-12-31 Sold Out -0.38%$38.88 - $59.42
($46.08)
$ 119.43159%Sold Out0
VRTXDaniel Loeb 2012-09-30 Add0.22%$48.38 - $59.07
($53.5)
$ 119.43123%Add 40%700,000
VRTXGeorge Soros 2012-09-30 Sold Out -0.09%$48.38 - $59.07
($53.5)
$ 119.43123%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VRTX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
VRTX Andreas Halvorsen 2014-12-31764,2000.320.42New Buy
VRTX Ken Fisher 2014-12-314,37800-4.68%
VRTX Vanguard Health Care Fund 2014-12-319,808,8604.052.7-16.93%
Premium Most recent portfolio changes are included for Premium Members only!


VRTX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Silva Paul MSVP & Corp Controller 2015-02-23Sell2,150$119.850.1view
Silva Paul MSVP & Corp Controller 2015-02-18Sell3,437$112.96.26view
LEIDEN JEFFREY MCEO & President 2015-02-18Sell32,250$112.896.27view
SMITH IAN FEVP & CFO 2015-02-18Sell10,350$112.896.27view
Sachdev AmitEVP, Policy, Access & Value 2015-02-18Sell5,937$112.896.27view
BOGER JOSHUA SDirector 2015-02-18Sell11,700$113.046.13view
BOGER JOSHUA SDirector 2015-02-11Sell5,700$108.6310.44view
Silva Paul MSVP & Corp Controller 2015-02-05Sell1,688$109.759.31view
BOGER JOSHUA SDirector 2015-02-04Sell5,700$108.8110.26view
Silva Paul MSVP & Corp Controller 2015-02-03Sell2,063$108.8910.18view

Press Releases about VRTX :

    Quarterly/Annual Reports about VRTX:

    News about VRTX:

    Articles On GuruFocus.com
    J.P. Morgan Chimes In With Ratings On BioTech Stocks Jan 06 2015 
    William Blair’s Top BioPharmaceutical Stock Picks for Q1 2015 Dec 23 2014 
    Weekly CFO Sells Highlight: Texas Instruments Inc, Royal Caribbean Cruises Ltd, Vertex Pharmaceutica Nov 09 2014 
    Weekly CFO Sells Highllight: Facebook Inc, Vertex Pharmaceuticals Inc, Nike Inc. Oct 05 2014 
    Vanguard Health Care Fund Buys Vertex Pharmaceuticals, Zoetis Inc, , Sells Cerner Corporation, AbbVi Aug 02 2013 
    Weekly Guru Bargains Highlights: MBI, VRTX, GRPN, PBI, PC Dec 16 2012 
    WEEKLY CFO SELLS HIGHLIGHT: AKRX, FIO, OVRL, VRTX Oct 21 2012 
    Idenix Pharmaceuticals Lagging Behind in Breakthrough Hepatitis C Drug Development Jul 13 2012 
    Weekly Top Insider Sells: GMCR, VRTX, CERN, and AGN May 14 2012 
    Vertex Could Climb On New Drug, VX-222 Success Apr 21 2012 


    More From Other Websites
    Biotech on the rise; Analyst likes Gilead Feb 23 2015
    What to Expect From Vertex Pharma's Next Cystic Fibrosis Drug Results Feb 23 2015
    VERTEX PHARMACEUTICALS INC / MA Financials Feb 20 2015
    VERTEX PHARMACEUTICALS INC / MA Files SEC form 10-K, Annual Report Feb 13 2015
    Vertex to Present at Upcoming Investor Conferences Feb 11 2015
    Vertex to Present at Upcoming Investor Conferences Feb 11 2015
    Stock Market News for February 06, 2015 - Market News Feb 06 2015
    [$$] Arkansas Reaches Settlement in Cystic Fibrosis Drug Suit Feb 06 2015
    First Hand Account: The White House Precision Medicine Announcement Jan 31 2015
    In cystic fibrosis drug launch prep, Vertex learns from Sovaldi mistakes Jan 30 2015
    Obama unveils precision medicine initiative Jan 30 2015
    Vertex Pharmaceuticals Slumps: VRTX Falls 5.9% in Session - Tale of the Tape Jan 30 2015
    White House targets precision medicine Jan 30 2015
    Baird Releases Comments After Vertex Earnings Call Jan 29 2015
    Vertex head of research, Broad co-founder David Altshuler to meet with Obama Friday Jan 29 2015
    Vertex Pharma Verging on Full Valuation Jan 29 2015
    Maxim Downgrades Vertex Pharmaceuticals After Earnings Jan 29 2015
    Vertex Pharmaceutical (VRTX) Stock Declines Today Following Earnings Realease Jan 29 2015
    Vertex Posts Wider 4Q Loss, Affirms Kalydeco Outlook - Analyst Blog Jan 29 2015
    Vertex Pharm downgraded by Needham and Maxim Group Jan 29 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK